Log in or Sign up for Free to view tailored content for your specialty!
Epilepsy News
High tissue 2HG level may increase preoperative seizure risk in those with mutant tumors
Higher tissue 2-hydroxyglutarate concentration appeared to increase risk for preoperative seizures in isocitrate dehydrogenase 1/2 mutant tumors, according to study results published in Neurology.
Injectable therapy for infantile epileptic disease to enter phase 3 trial
Amzell BV, a specialty pharmaceutical development company, announced it has a special protocol assessment agreement with the FDA for a phase 3 trial of its injectable infantile epileptic disease therapy.
Log in or Sign up for Free to view tailored content for your specialty!
Enzyme-inducing antiseizure medications linked to vascular disease
Patients who received enzyme-inducing antiseizure medications had increased risk for incident cardiovascular disease, according to results of a cohort study published in JAMA Neurology.
Antiseizure drug may improve spatial memory, executive function in AD
Levetiracetam was well tolerated and appeared to improve performance on spatial memory and executive function tasks among patients with Alzheimer’s disease, according to results of a randomized clinical trial in JAMA Neurology.
FDA approves Briviact for young children with partial-onset seizures
The FDA has approved an expanded indication for Briviact CV tablets, oral solution and injection, for treating partial-onset seizures among children as young as 1 month.
CBD gel reduces seizures in children with encephalopathies
Cannabidiol transdermal gel improved outcomes among children with developmental and epileptic encephalopathies, according to results of a nonrandomized controlled trial published in JAMA Network Open.
Cerebral cavernous malformations increase risk for seizures
Individuals with familial cerebral cavernous malformation had a high incidence rate of seizures, according to study findings published in Neurology.
Q&A: Study examines 'downstream economic burden' of adjunctive therapy in epilepsy
Findings published recently in Journal of Medical Economics demonstrated that patients with focal seizures who began first adjunctive therapy with eslicarbazepine acetate vs. brivaracetam had considerably larger reductions in medical costs.
Eslicarbazepine acetate adjunctive therapy reduces charges related to focal seizures
Patients with focal seizures who initiated first adjunctive therapy with eslicarbazepine acetate vs. brivaracetam had significantly larger reductions in medical charges, as well as in prescription charges unrelated to anti-seizure drugs.
Amyloid beta levels in blood may indicate risk for cognitive decline
Decreased levels of plasma amyloid beta 42 at midlife, but not late life, correlated with an increased risk for dementia and a “marginally higher” risk for mild cognitive impairment, according to findings published in Neurology.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read